Literature DB >> 12413646

Cannabis use and dimensions of psychosis in a nonclinical population of female subjects.

Hélène Verdoux1, F Sorbara, C Gindre, Joël D Swendsen, Jim van Os.   

Abstract

OBJECTIVE: The aim of the present study was to explore the pattern of associations between cannabis use and dimensions of psychosis in a nonclinical population of female subjects.
METHOD: The Community Assessment of Psychic Experiences (CAPE), a 42-item self-report questionnaire that evolved from the Peters et al. Delusions Inventory [Schizophr. Bull. 25 (1999) 553], was used to measure dimensions of psychosis in a sample of undergraduate female students (n=571). The participants were also asked to complete a self-report questionnaire collecting information on substance use.
RESULTS: Three correlated dimensions of positive, negative and depressive experiences were identified using principal components factor analysis. Frequency of cannabis use was independently associated with the intensity of both positive and negative psychotic experiences. No significant association was found between cannabis use and the depressive dimension, or between alcohol use and any of the three positive, negative and depressive dimensions.
CONCLUSION: This cross-sectional study supports the hypothesis that exposure to cannabis may induce the emergence of positive psychotic symptoms in subjects without clinical psychosis, and additionally suggests that cannabis users exhibit greater levels of negative symptoms. Prospective studies are required to explore the direction of causality and the impact of cannabis on the course of psychotic experiences in subjects from the general population.

Entities:  

Mesh:

Year:  2003        PMID: 12413646     DOI: 10.1016/s0920-9964(01)00401-7

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  14 in total

1.  Genetic Risk and Outcome of Psychosis (GROUP), a multi-site longitudinal cohort study focused on gene-environment interaction: objectives, sample characteristics, recruitment and assessment methods.

Authors:  Nikie Korver; Piotr J Quee; Heleen B M Boos; Claudia J P Simons; Lieuwe de Haan
Journal:  Int J Methods Psychiatr Res       Date:  2012-03-15       Impact factor: 4.035

Review 2.  Psychometric Properties of "Community Assessment of Psychic Experiences": Review and Meta-analyses.

Authors:  Winifred Mark; Timothea Toulopoulou
Journal:  Schizophr Bull       Date:  2015-07-06       Impact factor: 9.306

3.  Corticosteroid dependent and independent effects of a cannabinoid agonist on core temperature, motor activity, and prepulse inhibition of the acoustic startle reflex in Wistar rats.

Authors:  Avdesh Avdesh; Vincent Cornelisse; Mathew Thomas Martin-Iverson
Journal:  Psychopharmacology (Berl)       Date:  2011-09-27       Impact factor: 4.530

4.  Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways.

Authors:  Aine T Behan; Magdalena Hryniewiecka; Colm M P O'Tuathaigh; Anthony Kinsella; Mary Cannon; Maria Karayiorgou; Joseph A Gogos; John L Waddington; David R Cotter
Journal:  Neuropsychopharmacology       Date:  2012-03-21       Impact factor: 7.853

5.  Cannabis users differ from non-users on measures of personality and schizotypy.

Authors:  Daniel J Fridberg; Jennifer M Vollmer; Brian F O'Donnell; Patrick D Skosnik
Journal:  Psychiatry Res       Date:  2011-03-30       Impact factor: 3.222

6.  The Latent Taxonicity of Schizotypy in Biological Siblings of Probands With Schizophrenia.

Authors:  Richard J Linscott; Sarah E Morton
Journal:  Schizophr Bull       Date:  2018-06-06       Impact factor: 9.306

Review 7.  Cannabis-associated psychosis: current status of research.

Authors:  F Markus Leweke; Christoph W Gerth; Joachim Klosterkötter
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

8.  Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people.

Authors:  Cécile Henquet; Lydia Krabbendam; Janneke Spauwen; Charles Kaplan; Roselind Lieb; Hans-Ulrich Wittchen; Jim van Os
Journal:  BMJ       Date:  2004-12-01

Review 9.  Developmental precursors of psychosis.

Authors:  Matti Isohanni; Irene Isohanni; Hannu Koponen; Johanna Koskinen; Pekka Laine; Erika Lauronen; Jouko Miettunen; Pirjo Mäki; Kaisa Riala; Sami Räsänen; Kaisa Saari; Pekka Tienari; Juha Veijola; Graham Murray
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

10.  Prevalence of psychotic symptoms in substance users: a comparison across substances.

Authors:  Matthew J Smith; Jagadisha Thirthalli; Arbi Ben Abdallah; Robin M Murray; Linda B Cottler
Journal:  Compr Psychiatry       Date:  2008-09-23       Impact factor: 3.735

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.